Expanding decentralized clinical trials demands flexibility
October 5, 2022
Jane Myles, Curebase's VP of clinical trial innovation at Curebase sat down with HIMSS TV's Emily Olsen to discuss why flexibility is key to expanding decentralized clinical trials.
"It's important to be creative when overcoming obstacles to access to wider improvements in trial design and participation." - Jane Myles, VP of Clinical trial innovation at Curebase